News

By Laura Lovett June 18, 2018
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the only partner with a 25-year DBS legacy, and paves the way to our vision of the future of DBS with a fully integrated system from planning to programming," said Mike Daly, vice president and general...
How Sitra is fostering healthcare innovation in Finland at HIMSS Europe
By HIMSS TV June 18, 2018
Pia Heikkurinnen, theme specialist, capacity renewal at Sitra, talks about the support the Finnish government is giving Sitra to back digital health startups and other healthcare innovators.  
Indu Subaiya, co-founder of Health 2.0 talks about start-up community and European hospital IT leaders at HIMSS Europe
By HIMSS TV June 18, 2018
Indu Subaiya, co-founder of Health 2.0 and executive vice president at HIMSS, discusses the value in bridging the gap between the start-up community and European hospital IT leaders.
By Dave Muoio June 18, 2018
Pasadena, California-based Embodied announced today it has raised $22 million in Series A funding to support its AI and robotics platforms for improved care and wellness. The investment is led by Calibrate Ventures and Jazz Venture Partners, and had participation from previous backers including Osage University Partners, Intel Capital, Grishin Robotics, and others. “We are developing a software...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...

Scientist working in the lab at Helix. Photo courtesy of Helix. 

By Laura Lovett June 15, 2018
In the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healthcare space.    Whether it is uniting women switched at birth 72-years prior or settling neighborly feuds, consumer genomics have caught the public’s interest. The highest...
By Jonah Comstock June 14, 2018
Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional participation by F-Prime Capital and returning investor Thrive Capital. “Just as computer science has changed the world and transformed every industry, we think that in 10 to 20...
By Dave Muoio June 14, 2018
Biometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic investment by hearing instrument and specialty earphone company Sonion a/s, with additional participation from prior investors including TDF Ventures, GII LLC, and WSJ...
By Laura Lovett June 14, 2018
Mindstrong Health, a company that uses phone activity to measure mental health and behavior, has just closed a $15 million Series B funding round.  This newest backing brings the startups total financing to $29 million, and will be used to scale the business and advance commercial deployments with partners in the healthcare industry. Mindstrong is backed by ARCH Venture Partners, Berggruen...

Credit:

By Dave Muoio June 14, 2018
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal. The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch. "This device offers hope to...

Editor's Pick

more information steroid-pharm.com

our company steroid-pharm.com